Viibryd vs. Escitalopram
See how Viibryd and Escitalopram compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Viibryd is a newer SPARI antidepressant with a partial 5-HT1A agonist mechanism, while escitalopram is a well-established SSRI available as a low-cost generic.
Both carry a boxed warning for increased suicidal thoughts in children, teens, and young adults, and both require gradual titration over one to two weeks.
Escitalopram treats both depression and generalized anxiety and is approved for adolescents, while Viibryd is approved only for adult depression and must be taken with food.
Viibryd vs. Escitalopram Drug Summary
Viibryd
Viibryd (vilazodone) is a serotonin partial agonist and reuptake inhibitor (SPARI) approved to treat major depressive disorder in adults. It combines serotonin reuptake inhibition with partial activation of 5-HT1A receptors, a mechanism different from standard SSRIs. It's taken once daily with food, starting at 10 mg and titrating up to a 40 mg maintenance dose.
Escitalopram
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder in adults and adolescents 12 to 17, as well as generalized anxiety disorder in adults. It's taken once daily, starting at 10 mg for the first week before increasing to a 20 mg maintenance dose.
Viibryd vs. Escitalopram Side Effects
Viibryd
Escitalopram
Viibryd vs. Escitalopram Dosage
Viibryd
Escitalopram
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | Days 1-7 |
| Maximum dose | 40 mg once daily | Day 15 onward |
| Dose changes | 2 increases | Every 7 days |
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | Week 1 |
| Maximum dose | 20 mg once daily | Week 2 onward |
| Dose changes | 1 increase | Every week |
Viibryd
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | Days 1-7 |
| Maximum dose | 40 mg once daily | Day 15 onward |
| Dose changes | 2 increases | Every 7 days |
Escitalopram
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | Week 1 |
| Maximum dose | 20 mg once daily | Week 2 onward |
| Dose changes | 1 increase | Every week |
Viibryd vs. Escitalopram Indications
Viibryd
Viibryd is FDA-approved to treat major depressive disorder in adults. It has not been studied or approved for use in children or teens. Because food significantly boosts its absorption, it must be taken with a meal every day.
FDA-approved for major depressive disorder in adults
Not approved for pediatric depression
Must be taken with food for proper absorption
No FDA approval for anxiety disorders
Escitalopram
Escitalopram is FDA-approved for major depressive disorder in both adults and adolescents ages 12 to 17, as well as generalized anxiety disorder in adults. It is not approved for bipolar depression or for children under 12. Its broader age and diagnosis range make it a common first-line choice.
FDA-approved for MDD in adults and teens 12-17
FDA-approved for generalized anxiety disorder in adults
Not approved for bipolar depression
Available as tablet or oral solution
Viibryd vs. Escitalopram Pros and Cons
Viibryd
Viibryd's dual mechanism sets it apart from standard SSRIs, but it comes with a strict food requirement and a much higher price tag since no affordable generic exists. Insurance coverage can be inconsistent given its brand-only status.
Pros
Additional non-SSRI mechanism (5-HT1A partial agonism) may help when SSRIs alone haven't worked
Some trial data suggest lower sexual side effect rates than typical SSRIs
Partial 5-HT1A agonist activity may add anxiolytic benefit beyond typical SSRI action, based on its receptor pharmacology
Cons
Must be taken with food or absorption drops significantly
No affordable generic available, keeping cost high (roughly $380 to $650 per month)
Higher rates of GI side effects like diarrhea and nausea
Escitalopram
Escitalopram is a well-studied, inexpensive generic with FDA approval for both depression and anxiety, including in teens. Its side effect profile is typical for SSRIs, including sexual dysfunction, but it lacks Viibryd's distinct receptor mechanism.
Pros
FDA-approved for both depression and generalized anxiety disorder
Approved for adolescents 12-17 with depression
Widely available as a low-cost generic (roughly $8 to $56 per month)
Cons
Higher reported rates of sexual side effects, like ejaculation disorder
Standard SSRI mechanism may not help patients who haven't responded to SSRIs
Fewer alternative options if SSRI class effects are intolerable
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.